Medical/Pharmaceuticals
Internationally Renowned Orthopaedic Surgeon Thought Leaders Join Formus Labs' Clinical Advisory Board
AUCKLAND, New Zealand, Feb. 15, 2023 /PRNewswire/ -- Formus Labs, creator of the first automated 3D AI-enabled pre-operative planner for joint replacement surgeries, today announces that arthroplasty experts DrJ. Bohannon Mason, Dr. Atul Kamath, and Dr. James A. Germano will join its clinical adv...
2023-02-15 21:00
1837
Kubota Tractor Corporation Implements Syncron For Streamlined Retail Inventory Management and Exceptional Dealer Network Service
Leading distributor of agricultural and construction machinery equipment selects Syncron Retail Inventory for optimized dealer inventory management that aligns aftermarket strategies with dealer networks for superior customer service. CHICAGO, Feb. 15, 2023 /PRNewswire/ -- Syncron today announce...
2023-02-15 21:00
2679
Flagship Biosciences Applauded by Frost & Sullivan for Changing Biomarker Analysis to Find Biomarkers that Aid Drug Development and Diagnostics
Digital pathology solutions are increasingly used in the preclinical and clinical development phases, particularly toxicologic pathology and clinical trials, speeding up the process and curtailing expenses. SAN ANTONIO, Feb. 15, 2023 /PRNewswire/ -- Frost & Sullivan assessed the artificial intel...
2023-02-15 21:00
2127
Henlius Announces U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar Trastuzumab HLX02
* The first Chinese biosimilar approved in both China and the EU, and potentially to be approved in the U.S. - * HLX02 (trastuzumab for injection, trade name in China: HANQUYOU; trade name inEurope: Zercepac®; trade names in Australia: Tuzucip® and Trastucip®) has been approved in more than 3...
2023-02-15 16:49
3076
Mindray Revolutionizes the Way of Using Ultrasound with TE Air, Its First Wireless Handheld Ultrasound System
SHENZHEN, China, Feb. 15, 2023 /PRNewswire/ -- Mindray
2023-02-15 14:40
3595
GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS
- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with DAA Therapies - Review of implementation science projects toward HCV Elimination by 2030 in Asia proved effective in improving patient outcomes - Efficacy ...
2023-02-15 10:00
2662
Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy
ROCKVILLE, Md. and SUZHOU, China, Feb. 15, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...
2023-02-15 08:00
3916
Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)
Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301. MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Au...
2023-02-15 05:10
2051
Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine
MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the successful completion of its joint research project conducted with Heidelberg University Hospital (UKHD) under the Research Cooperation Agreement announced inFebrua...
2023-02-15 04:51
2047
Eurofins Discovery Collaborating with Invasight on Cancer Therapies
SAN DIEGO, Feb. 14, 2023 /PRNewswire/ -- Eurofins Discovery, the leading provider of products and services to the drug discovery industry, today announced its collaboration withInvasight, a Switzerland-based biotech developing cancer therapies. The collaboration focuses on advancing first-in-cla...
2023-02-15 00:10
2208
CJ Biomaterials Teams with Banila Co. to Develop New 100% Biobased Cosmetic Jar using Amorphous PHA
WOBURN, Mass., Feb. 14, 2023 /PRNewswire/ -- CJ Biomaterials, Inc., a division ofSouth Korea-based CJ CheilJedang and a primary producer of polyhydroxyalkanoates (PHAs), has produced the first cosmetic jar based on their amorphous PHA technology, under the tradename, PHACT™. The cosmetic jar was...
2023-02-14 22:00
2440
Metabolon to Offer Targeted Panels and Assays to Aid in Dysregulated Glucose Status and Related Research
Targeted metabolomics panels and assays provide absolute quantitation for advanced research into the relationship of metabolites to glucose metabolism MORRISVILLE, N.C., Feb. 14, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variet...
2023-02-14 21:04
2012
Athachi Group showcases 'Trust Nature™' initiative to Union Ministers; The 'Trust Nature™' philosophy is akin to Yoga to the world
NEW DELHI, Feb. 14, 2023 /PRNewswire/ -- The senior management team of Athachi Group, a diversified business group headquartered in Palakkad, Kerala, with nature close to its heart across its operations inIndia and the UAE, met the Union Ministers recently in the capital and presented its 'Trust ...
2023-02-14 11:30
2448
Point-of-Care Ultrasound Training in Under-Resourced Region Improves Physician Knowledge
Study of 100+ Patients Published in Journal of Radiology Nursing ROCKVILLE, Md., Feb. 13, 2023 /PRNewswire/ -- A study published for the March 2023 issue of Journal of Radiology Nursing demonstrates that a short training course in Point-of-Care Ultrasound (POCUS) can measurably improve physician...
2023-02-13 22:00
1821
HistoSonics Announces FDA Approval of its Pivotal IDE #HOPE4KIDNEY Trial
Company to Utilize its New Edison™ System with Advanced Imaging Features for Use in Kidney Tumors MINNEAPOLIS, Feb. 13, 2023 /PRNewswire/ -- HistoSonics, (www.histosonics.com ), the developer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today the US Food a...
2023-02-13 22:00
2002
U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine
* Modified agreement also includes the development of an updated vaccine in fall 2023 GAITHERSBURG, Md., Feb. 13, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, toda...
2023-02-13 21:00
3237
Completion Of The First Batch Of Subject Enrollment For The Phase I Clinical Trial Of The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610
TAIZHOU, China, Feb. 13, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that the Group has recently completed the first batch of subject enrollment for its novel adjuvanted recombinant shingles vaccine, ...
2023-02-13 15:02
3780
Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease
TAMPA, Fla., Feb. 13, 2023 /PRNewswire/ -- Concept Medical Inc.
2023-02-13 14:53
2322
Boan Biotech's Investigational Anti-CD25 Antibody BA1106 Administered for First Patient in Phase I Clinical Trial
YANTAI, China, Feb. 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that BA1106, an investigational non-IL-2 blocking anti-CD25 antibody developed by its subsidiary Boan Biotech, has been administered for the first patient in a Phase I clinical trial. This trial is designed to evaluate...
2023-02-13 08:39
3019
VISTA Eye Specialist to Showcase Latest Eye Care Technology
PETALING JAYA, Malaysia, Feb. 13, 2023 /PRNewswire/ -- In collaboration with Ziemer Ophthalmic Systems AG (Ziemer), one of the leading Ophthalmic companies based inSwitzerland, VISTA Eye Specialist (VISTA) will be hosting surgeons from around the world on 22nd February, to participate in a variet...
2023-02-13 08:00
4817
Week's Top Stories
Most Reposted
Agoda releases generative AI film to capture the joy of travel
[Picked up by 348 media titles]
2024-12-10 10:00
Singapore's IMAGINE AI: Largest Global Gathering to Shape the Future of Healthcare with AI Innovations
[Picked up by 316 media titles]
2024-12-06 10:41
Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
[Picked up by 313 media titles]
2024-12-10 09:00Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
[Picked up by 306 media titles]
2024-12-09 10:00
CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea
[Picked up by 283 media titles]
2024-12-08 20:07Most Read
Singapore's IMAGINE AI: Largest Global Gathering to Shape the Future of Healthcare with AI Innovations
2024-12-06 10:41
6974
Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations
2024-12-06 20:15
6498
BROOKLYN NETS AND PHOENIX SUNS TO PLAY TWO PRESEASON GAMES IN MACAO IN OCTOBER 2025
2024-12-06 21:09
5697
